Close
Nordic 9Nordic 9

Unibio (private company)

Denmark unibio.dk
See something wrong or missing? Let us know
Offices:Odense
Industry:BiotechHealth services
Business model:B2B

Unibio is a biotechnology company which owns the rights to a unique fermentation technology – the U-Loop technology – which has been developed in cooperation with DTU and is the result of more than 30 years of research and development activities.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 100M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Unibio

Name Criteria
United Kingdom Achilles Therapeutics
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Germany Adrenomed AG
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Iceland Alvotech
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Aprea Therapeutics
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany Atai Life Sciences
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Biofidelity
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany CatalYm
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Sweden Cavidi
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Top